Patent · US Active

Method for fully automated synthesis of 16β-18F-fluoro-5α-dihydrotestosterone (18F-FDHT)

US10065985B2 · kind B2 · utility

0Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 3, 2016
Grant dateSep 4, 2018
Priority date
Expiry dateFeb 3, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J75/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The automated synthesis of clinically relevant amounts of 16β-18F-fluoro-5α-dihydrotestosterone (18F-FDHT) using a commercially available radiosynthesizer. Synthesis was performed in 90 minutes with a decay-corrected radiochemical yield of 29±5%. The specific activity was 4.6 Ci/μmol (170 GBq/μmol) at end of formulation with a starting activity of 1.0 Ci (37 GBq). The formulated 18F-FDHT yielded sufficient activity for multiple patient doses and passed all quality control tests required for routine clinical use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.